Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Tumori ; 81(1): 23-31, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7754537

RESUMO

AIMS AND BACKGROUND: In the treatment of pancreatic carcinomas, one modality is intraoperative radiotherapy (IORT). A study was carried out to assess the feasibility of IORT alone or in a multimodality approach with postoperative adjuvant chemotherapy and external radiotherapy and to compare local control and survival of patients. Another objective of this retrospective study was to verify prognostic factors in resected patients treated with IORT. METHODS: From January 1985 through September 1992, 54 adenocarcinomas of the pancreas (unresectable and resected patients) were treated with IORT by electron beam at the San Raffaele Hospital and then analyzed. Comparison was also carried out between IORT-treated resected patients and a non-randomized control group of resected patients treated without IORT in the same period. RESULTS: In unresectable patients treated by laparotomy bypass and IORT, overall median survival was 6 months and 8 months in non-metastatic patients. Relief of severe pain present in 14 patients was observed in 85% within 12 days of IORT. As regards resected patients, the most important finding was that significantly better local control resulted from IORT. In fact, overall, local relapses were 25% in the IORT group and 55.8% in the non-IORT group (control group); instead, survival of the IORT group was not significantly longer than that of the control group. From a statistical analysis of resected patients treated with IORT and performed on prognostic factors on the basis of available data, survival was significantly influenced by tumor pathologic grading and diameter; postoperative adjuvant therapy was not a significant prognosis factor. CONCLUSIONS: IORT has a role in local control of unresectable pancreatic carcinomas and in control of resultant severe pain. In resected patients, IORT is effective in decreasing local recurrences but has little impact on survival. To obtain more satisfactory results, new and more effective adjuvant therapies and better abdominal prophylaxis should be tested.


Assuntos
Adenocarcinoma/radioterapia , Adenocarcinoma/cirurgia , Antineoplásicos/uso terapêutico , Elétrons , Cuidados Intraoperatórios , Neoplasias Pancreáticas/radioterapia , Neoplasias Pancreáticas/cirurgia , Adenocarcinoma/tratamento farmacológico , Adulto , Idoso , Quimioterapia Adjuvante , Terapia Combinada , Estudos de Viabilidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Neoplasias Pancreáticas/tratamento farmacológico , Radioterapia Adjuvante , Estudos Retrospectivos , Análise de Sobrevida
2.
Radiol Med ; 80(4 Suppl 1): 93-8, 1990 Oct.
Artigo em Italiano | MEDLINE | ID: mdl-2251427

RESUMO

In San Raffaele Institute a simplified procedure for intraoperative radiotherapy (IORT) was developed. An applicator system of "guide-containers" was used to facilitate the use of IORT (with electron beam) with different treatment fields. Application of this technique was studied; no IORT related complications was observed in phase I and clinical good results are reported.


Assuntos
Elétrons , Neoplasias Pancreáticas/radioterapia , Terapia Combinada , Humanos , Período Intraoperatório , Neoplasias Pancreáticas/cirurgia , Projetos Piloto , Radioterapia/instrumentação , Radioterapia/métodos
3.
J Biol Regul Homeost Agents ; 4(4): 150-2, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2128988

RESUMO

The endocrine effects of ovariectomy need to be further investigated. The present study was carried out to evaluate the influence of the adjuvant ovariectomy on the mastectomy-induced changes in PRL response to TRH in breast cancer. The study included 34 patients with locally limited breast carcinoma, 18 of whom were treated with radical mastectomy, whereas the other 16 underwent mastectomy plus adjuvant ovariectomy. PRL secretion in response to TRH (200 mcg I.V. as bolus) was evaluated one day before and 7 days after surgery. In patients treated with mastectomy only, PRL increase after TRH was significantly higher after surgery than before. On the contrary, no difference was seen in patients treated with mastectomy plus ovariectomy. This study shows that the adjuvant ovariectomy may block the increase in PRL response to TRH induced by mastectomy in breast cancer.


Assuntos
Neoplasias da Mama/cirurgia , Prolactina/sangue , Adulto , Idoso , Neoplasias da Mama/sangue , Feminino , Humanos , Mastectomia , Pessoa de Meia-Idade , Ovariectomia , Hormônio Liberador de Tireotropina/farmacologia
4.
Kos ; 6(53): 37-41, 1990.
Artigo em Italiano | MEDLINE | ID: mdl-11629907
7.
Kos ; 5(42): 44-52, 1989 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-11637877
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...